Preferential inhibition of L- and N-type calcium channels in the rat hippocampal neurons by cilnidipine-Reference-Cited by-同舟云学术

Preferential inhibition of L- and N-type calcium channels in the rat hippocampal neurons by cilnidipine

Published:2000-01 Issue:1-2 Volume:854 Page:6-10
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Murai Yoshinaka,Uneyama Hisayuki,Ishibashi Hitoshi,Takahama Kazuo,Akaike Norio

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference20 articles.

1. Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms;Akaike;Jpn. J. Physiol.,1994

2. The naming of voltage-gated calcium channels;Birnbaumer;Neuron,1994

3. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic change;Choi;Trends Neurosci.,1988

4. Effect of cilnidipine, a novel dihydropyridine Ca++-channel antagonist, on N-type Ca++ channel in rat dorsal root ganglion neurons;Fujii;J. Pharmacol. Exp. Ther.,1997

5. Brain edema and cerebrovascular permeability during cerebral ischemia in rats;Hatashita;Stroke,1990

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of N-Bromosuccinimide–Water Combination as a Green Reagents for a Validated Indirect Spectrophotometric Determination of Some Antihypertensive Drugs: An Application to Their Monitoring in Marketed Tablets and Capsules;Journal of AOAC International;2023-12-01

2. Angiotensin AT1A receptor signal switching in Agouti-related peptide neurons mediates metabolic rate adaptation during obesity;Cell Reports;2023-08

3. Inhibition of glutamate release by cilnidipine in rat cerebrocortical nerve terminals (synaptosomes);NeuroReport;2017-06-14

4. Spectrophotometric Method for Determination of Five 1,4-Dihydropyridine Drugs Using N-Bromosuccinimide and Indigo Carmine Dye;International Journal of Spectroscopy;2013-08-22

5. Cilnidipine: A New Generation Ca2+Channel Blocker with Inhibitory Action on Sympathetic Neurotransmitter Release;Cardiovascular Therapeutics;2009-06